期刊文献+

吡格列酮对Aβ_(25-35)所致痴呆大鼠的学习记忆能力及海马内氧化应激的影响 被引量:3

Effects of pioglitazone on learning and memory deficits and oxidative stress in the hippocampus of Aβ_(25-35) induced AD rats
下载PDF
导出
摘要 目的研究吡格列酮对Aβ25-35所致痴呆大鼠学习记忆能力和海马内氧化应激反应的影响。方法侧脑室注射Aβ25-35建立大鼠AD模型,吡格列酮(40mg/kg、80mg/kg)灌胃21d,次日行Morris水迷宫实验,前5天定位航行训练,第6天进行空间探索实验。行为学实验后第2天麻醉,断头取脑,提取脑组织匀浆,以备ELISA实验。ELISA实验研究大鼠海马内的氧化应激反应。结果 Morris水迷宫结果显示,模型组大鼠潜伏期较空白对照组明显延长,而穿过平台次数和平台滞留时间缩短。经吡格列酮治疗后,潜伏期显著缩短,穿过平台次数和滞留时间也相应增加。ELISA结果显示,模型组大鼠海马内酶性抗氧化剂GSH-Px和SOD活性较空白对照组明显降低,而脂质过氧化产物MDA含量增加。经吡格列酮治疗后,GSH-Px和SOD活性提高,MDA产生减少。结论吡格列酮能改善痴呆大鼠的学习记忆能力,其机制可能与对抗海马内的氧化应激反应有关。 Objective To study the effects of pioglitazone(Pio)on learning and memory deficits and oxidative stress in the hippocampus of Aβ25-35 induced AD rats.Methods Intracerebroventricular injection of Aβ25-35 to produce the model of AD.And the rats were administrated with Pio(40,80mg/kg,ig.)for 21 days.Morris water maze test was used to test learning and memory ability of the rats.The first 5days,place navigation test was carried out followed by the spatial probe test on the sixth day.After behavior test,the rats were sacrificed for preparing tissue homogenate.And ELISA was used to measure the activity of GSH-Px and SOD and the level of MDA.Results Morris water maze test showed that the escape latency was prolonged in rats of model group compared to the control group while the number of crossing the platform and time spent on the platform were reduced.After administration of Pio,the escape latency was decreased and the number of crossing the platform and time spent on the platform were increased.Results of ELISA showed that Pio increased the activity of GSH-Px and SOD and decreased the level of MDA in the AD rats.Conclusions Pio could improve the learning and memory ability of AD rats and the mechanism maybe related to attenuating oxidative stress in the hippocampus.
出处 《贵州医药》 CAS 2016年第2期119-122,共4页 Guizhou Medical Journal
关键词 AΒ25-35 吡格列酮 学习记忆能力 氧化应激 Aβ25-35 Pioglitazone Learning and memory Oxidative stress
  • 相关文献

参考文献18

  • 1Braak H,Braak E.Evolution of neuronal changes in the course of Alzheimer's disease[J].J Neural Transm Suppl,1998,53:127-140. 被引量:1
  • 2Ferri CP,Prince M,Brayne C,et al.Global prevalence of dementia:a Delphi consensus study[J].The Lancet,2006,366(9503):2112-2117. 被引量:1
  • 3Priller C,Bauer T,Mitteregger G,et al.Synapse formation and function is modulated by the amyloid precursor protein[J].The Journal of neuroscience,2006,26(27):7212-7221. 被引量:1
  • 4Price JL,McKeel Jr DW,Buckles VD,et al.Neuropathology of nondemented aging:Presumptive evidence for preclinical Alzheimer disease[J].Neurobiology of aging,2009,30(7):1026-1036. 被引量:1
  • 5Markesbery WR,Schmitt FA,Kryscio RJ,et al.NEuropathologic substrate of mild cognitive impairment[J].Archives of Neurology,2006,63(1):38-46. 被引量:1
  • 6Meng QH,Lou FL,Hou WX,et al.Acetylpuerarin reduces inflammation and improves memory function in a rat model of Alzheimer's disease induced by Abeta1-42[J].Pharmazie,2013,68(11):904-908. 被引量:1
  • 7Bornemann KD,Wiederhold KH,Pauli C,et al.Abeta-induced inflammatory processes in microglia cells of APP23transgenic mice[J].Am J Pathol,2001,158(1):63-73. 被引量:1
  • 8Viscoli CM,Brass LM,Carolei A,et al.Pioglitazone for secondary prevention after ischemic stroke and transient ischemic attack:rationale and design of the Insulin Resistance Intervention after Stroke Trial[J].Am Heart J,2014,168(6):823-829. 被引量:1
  • 9Ricote M,Huang JT,Welch JS,et al.The peroxisome proliferator-activated receptor(PPARgamma)as a regulator of monocyte/macrophage function[J].J Leukoc Biol,1999,66(5):733-739. 被引量:1
  • 10Sundararajan S,Gamboa JL,Victor NA,et al.Peroxisome proliferator-activated receptor-gamma ligands reduce inflammation and infarction size in transient focal ischemia[J].Neuroscience,2005,130(3):685-696. 被引量:1

同被引文献24

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部